Table 1 Evaluative characteristics according to clinical scenarios
From: Proceedings of Réanimation 2018, the French Intensive Care Society International Congress
CS 1 (n = 12; 27.9%) | CS 2 (n = 14; 32.5%) | CS 3 (n = 4; 9.3%) | CS 4 (n = 5; 11.6%) | CS 5 (n = 8; 18.6%) | |
|---|---|---|---|---|---|
Age (med ± DS), years | 66.5 ± 13.9 | 72.5 ± 17.8 | 49.5 ± 27.6 | 62 ± 11.6 | 50 ± 22.2 |
SAPS II (med ± DS) | 36 ± 21.9 | 30 ± 11.9 | 39 ± 6.9 | 28 ± 7.8 | 23.5 ± 25.2 |
APACHE II (med ± DS) | 18.5 ± 10.5 | 19 ± 7.06 | 18 ± 2.06 | 14 ± 2.28 | 16 ± 10.7 |
Hypertension history : n (%) | 6 (50) | 11 (78) | 2 (50) | 0 | 1 (12.5) |
PaO2/FiO2 (med ± DS), mmHg | 170 ± 68.8 | 161.6 ± 71.8 | 159.1 ± 124.6 | 168.5 ± 13.6 | 190 ± 64.5 |
Need IMV n (%) | 4 (33.3) | 4 (28.6) | 2 (50) | 2 (40) | 5 (62.5) |
NIV only n (%) | 8 (66.6) | 10 (71.4) | 2 (50) | 3 (60) | 3 (37.5) |
MV length (med ± DS), days | 12 ± 57.9 | 9 ± 12.2 | 10 ± 8.5 | 9 ± 3 | 59 ± 64.5 |
LOS (med ± DS), days | 8 ± 5.63 | 3 ± 21.5 | 1 ± 2.5 | 8 ± 4.6 | 2 ± 3.9 |
Mortality n (%) | 3 (25) | 3 (21.4) | 3 (75) | 2 (40) | 4 (50) |